Who owns AEROVATE THERAPEUTICS INC?
- Ticker: AVTE
- CUSIP Number: 008064107
Tip: Access positions for across all investors
Analyze quarterly positions in Aerovate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aerovate Therapeutics stock
Who bought or sold AEROVATE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 8.3M | $187M | 0% | Dec 2023 |
|
Atlas Venture Life Science Advisors | 2.0M | $46M | 0% | Dec 2023 |
|
Baker Bros. Advisors | 1.7M | $38M | -14% | Dec 2023 |
|
Cormorant Asset Management | 1.2M | $27M | -22% | Dec 2023 |
|
Frazier Life Sciences Management | 1.2M | $27M | 0% | Dec 2023 |
|
Dr. Jeffrey R. Jay, M.D. | 1.0M | $24M | -5% | Dec 2023 |
|
OrbiMed Advisors | 757k | $17M | 0% | Dec 2023 |
|
Vanguard Group | 627k | $14M | 5% | Dec 2023 |
|
Point72 Asset Management | 442k | $10M | 100% | Dec 2023 |
|
Octagon Capital Advisors | 404k | $9.1M | -19% | Dec 2023 |
|
Paradigm Biocapital Advisors | 143k | $3.2M | 100% | Dec 2023 |
|
Hudson Bay Capital Management | 103k | $2.3M | 100% | Dec 2023 |
|
Nantahala Capital Management | 91k | $2.1M | -4% | Dec 2023 |
|
Fred Alger Management | 37k | $826k | 47% | Dec 2023 |
|
Charles Schwab Investment Management | 30k | $669k | 0% | Dec 2023 |
|
Bank of New York Mellon | 28k | $818k | -24% | Mar 2024 |
|
Bank of America Corporation | 23k | $514k | 120% | Dec 2023 |
|
ALPS Advisors | 19k | $424k | -8% | Dec 2023 |
|
Parkwood | 16k | $357k | -24% | Dec 2023 |
|
Barclays | 15k | $348k | 300% | Dec 2023 |
|
Dimensional Fund Advisors | 15k | $339k | -27% | Dec 2023 |
|
Rhumbline Advisers | 14k | $320k | 1% | Dec 2023 |
|
Jane Street | 13k | $297k | 100% | Dec 2023 |
|
Alliancebernstein | 13k | $297k | 5% | Dec 2023 |
|
UBS Group | 12k | $277k | 9% | Dec 2023 |
|
Eventide Asset Management | 12k | $276k | 100% | Dec 2023 |
|
Golden State Equity Partners | 11k | $246k | 3% | Dec 2023 |
|
Two Sigma Investments | 9.8k | $221k | -17% | Dec 2023 |
|
Hrt Financial | 9.4k | $213k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 7.5k | $169k | 1% | Dec 2023 |
|
American International | 5.6k | $126k | 0% | Dec 2023 |
|
MetLife Investment Advisors | 5.2k | $118k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 5.0k | $113k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 4.3k | $97k | 0% | Dec 2023 |
|
Royal Bank of Canada | 3.5k | $79k | 148% | Dec 2023 |
|
Wells Fargo & Company | 2.9k | $66k | 29% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.3k | $52k | 0% | Dec 2023 |
|
Citigroup | 2.1k | $47k | 884% | Dec 2023 |
|
Legal & General Group | 1.7k | $38k | -78% | Dec 2023 |
|
Summit Investment Advisors | 772.00 | $18k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 701.00 | $16k | 0% | Dec 2023 |
|
Fortitude Family Office | 416.00 | $12k | 0% | Mar 2024 |
|
Amalgamated Bank | 347.00 | $10k | -76% | Mar 2024 |
|
GAMMA Investing | 94.00 | $2.8k | 18% | Mar 2024 |
|
CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Aerovate Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Sep 2023 | 53k | $724k |
Swiss National Bank | Sep 2023 | 21k | $288k |
Squarepoint Ops | Sep 2023 | 18k | $239k |